All In MedTech

Device Trial Radar · NCT06742801

Onyx™ Liquid Embolic IDE Clinical Study

PELE IDE Clinical Study, Peripheral Onyx™ Liquid Embolic Safety and Effectiveness of The Onyx™ LES for Embolization of Arterial Hemorrhage in the Peripheral Vasculature

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

119

Planned (sponsor's estimate)

Start

May 9, 2025

Primary completion

Apr 2027

Study completion May 2027

Sponsor

Lead sponsor
Medtronic EndovascularPublic (MDT)
Sponsor type
Industry
First posted
Dec 19, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.

Conditions

  • Peripheral Arterial Hemorrhage
  • Trauma
  • GI Bleed
  • Ulcer
  • Hemorrhage

Interventions

  • Onyx™ Liquid Embolic SystemDevice

    The proposed indication for Onyx™ LES is: Onyx™ LES is indicated for the embolization of arterial hemorrhage in the peripheral vasculature.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from Arterial HemorrhageTime frame: Through 30 days post-index procedure
  2. Freedom from System-related Major Adverse Events (MAE)Time frame: Through 30 days post-index procedure

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Phoenix, Arizona · Recruiting

  • University of California, Irvine

    Irvine, California · Recruiting

  • University of California Los Angeles

    Los Angeles, California · Recruiting

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.